首页> 外文期刊>ACS applied materials & interfaces >Supramolecular Aggregate as a High-Efficiency Gene Carrier Mediated with Optimized Assembly Structure
【24h】

Supramolecular Aggregate as a High-Efficiency Gene Carrier Mediated with Optimized Assembly Structure

机译:超分子聚集体是通过优化装配结构介导的高效基因载体。

获取原文
获取原文并翻译 | 示例
       

摘要

For cancer gene therapy, a safe and high efficient gene carrier is a must. To resolve the contradiction between gene transfection efficiency and cytotoxicity, many polymers with complex topological structures have been synthesized, although their synthesis. processes and structure control, are difficult as well as the high molecular weight also bring high cytotoxicity. We proposed an alternative strategy that uses suptamolecular inclusion to construct the aggregate from the small molecules for gene delivery, and to further explore the relationship between the topological assembly structure and their ability to deliver gene. Herein, PEI-1.8k conjugating beta-CD through 6-hydroxyl (PEI-6-CD) and 2-hydroXyl (PEI-2-CD) have been synthesized respectively and then assembled with diferrocene (Fc)-ended polyethylene glycol (PEG-Fc). The obtained aggregates were then used to deliver MMP-9 shRNA plasmid for MCF-7 cancer therapy. It was found that the higher gene transfection efficiency can be obtained by selecting PEI-2-CD as the host and tuning the host/guest molar ratios. With the rational modulation of supramolecular architectures, the aggregate played the functions similar to macromolecles. which exhibit higher transfection efficiency than PEI-25k, but show much lower cytotoxicity because of the, nature of small/low molecules. In vitro and in vivo assays confirmed that the aggregate could deliver MMP-9 shRNA,plasmid, effectively into MCF-7 cells. and then downregulate MMP-9 expression, which induced the significant MCF-7 cell apoptosis, as well inhibit MCF-7 tumor growth with low toxicity. The supramolecular aggregates maybe become a promising carrier for cancer gene therapy and also provided an alternative strategy for designing new gene carriers.
机译:对于癌症基因治疗,必须有安全高效的基因载体。为了解决基因转染效率和细胞毒性之间的矛盾,尽管合成了许多具有复杂拓扑结构的聚合物。过程和结构控制困难,以及高分子量也带来高细胞毒性。我们提出了一种替代策略,使用超分子包涵体从小分子构建聚集体以进行基因传递,并进一步探讨拓扑装配结构与其传递基因能力之间的关系。在此,分别合成了通过6-羟基(PEI-6-CD)和2-羟基(PEI-2-CD)结合β-CD的PEI-1.8k,然后将其与端有二茂铁(Fc)的聚乙二醇(PEG)组装在一起-Fc)。然后将获得的聚集体用于递送用于MCF-7癌症治疗的MMP-9 shRNA质粒。发现通过选择PEI-2-CD作为宿主并调节宿主/客人的摩尔比可以获得更高的基因转染效率。通过超分子结构的合理调节,聚集体发挥了类似于大分子的功能。与PEI-25k相比,它们的转染效率更高,但由于小分子/低分子的特性,其细胞毒性要低得多。体外和体内试验证实,聚集体可以有效地将MMP-9 shRNA质粒传递到MCF-7细胞中。然后下调MMP-9的表达,从而诱导MCF-7细胞明显凋亡,并以低毒性抑制MCF-7肿瘤的生长。超分子聚集体可能成为癌症基因治疗的有希望的载体,也为设计新的基因载体提供了另一种策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号